Cryo-Cell International Inc
CCEL4.990USD
+0.030+0.60%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
40.24MCap. mercado
312.64P/E TTM
Más Datos de Cryo-Cell International Inc Compañía
Cryo-Cell International, Inc. is a cord blood banking company. The Company operates through three segments: cellular processing and cryogenic storage for family use, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells; manufacture of PrepaCyte CB Processing System (PrepaCyte CB) units, the processing technology used to process umbilical cord blood stem cells, and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The Company stores approximately 235,000 cord blood and cord tissue specimens. The specimens are stored in commercially available cryogenic storage units at its technologically and operationally advanced facility. The Company markets its cord blood stem cell preservation services directly to expectant parents and by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals.
Información de la empresa
Símbolo de cotizaciónCCEL
Nombre de la empresaCryo-Cell International Inc
Fecha de salida a bolsaApr 04, 1994
Director ejecutivoMr. Mark L. Portnoy
Número de empleados82
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 04
Dirección700 Brooker Creek Blvd
CiudadOLDSMAR
Bolsa de valoresNYSE American Consolidated
PaísUnited States of America
Código postal34677
Teléfono18137492104
Sitio Webhttps://www.cryo-cell.com/
Símbolo de cotizaciónCCEL
Fecha de salida a bolsaApr 04, 1994
Director ejecutivoMr. Mark L. Portnoy
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.57M
--
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
+14.88%
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
45.40K
--
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Dr. Joanne Kurtzberg, M.D.
Dr. Joanne Kurtzberg, M.D.
Medical Director
Medical Director
--
--
Ms. Irene Smith
Ms. Irene Smith
Executive Assistant / Office Manager
Executive Assistant / Office Manager
--
--
Mr. Mark L. Portnoy
Mr. Mark L. Portnoy
Co-Chief Executive Officer, Director
Co-Chief Executive Officer, Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David I. Portnoy
Mr. David I. Portnoy
Chairman of the Board, Co-Chief Executive Officer
Chairman of the Board, Co-Chief Executive Officer
1.57M
--
Mr. Oleg Mikulinsky
Mr. Oleg Mikulinsky
Chief Information Officer
Chief Information Officer
104.35K
--
Mr. Harold D. Berger, CPA
Mr. Harold D. Berger, CPA
Independent Director
Independent Director
57.90K
+14.88%
Ms. Jill M. Taymans
Ms. Jill M. Taymans
Chief Financial Officer, Vice President - Finance
Chief Financial Officer, Vice President - Finance
45.40K
--
Mr. Daniel Mizrahi
Mr. Daniel Mizrahi
Independent Director
Independent Director
30.63K
--
Dr. Joanne Kurtzberg, M.D.
Dr. Joanne Kurtzberg, M.D.
Medical Director
Medical Director
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Processing and storage fees
7.87M
98.71%
Public banking revenue
82.08K
1.03%
Product revenue
20.91K
0.26%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Processing and storage fees
7.87M
98.71%
Public banking revenue
82.08K
1.03%
Product revenue
20.91K
0.26%
Estadísticas de accionistas
Actualizado: sáb., 17 de may
Actualizado: sáb., 17 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Portnoy (David I)
19.50%
Portnoy (Mark)
11.61%
Fleishman (Adam)
6.32%
Hamilton Lane Advisors, LLC
5.09%
SFI Advisors LLC
2.05%
Other
55.43%
Accionistas
Accionistas
Proporción
Portnoy (David I)
19.50%
Portnoy (Mark)
11.61%
Fleishman (Adam)
6.32%
Hamilton Lane Advisors, LLC
5.09%
SFI Advisors LLC
2.05%
Other
55.43%
Tipos de accionistas
Accionistas
Proporción
Individual Investor
40.39%
Investment Advisor
6.26%
Private Equity
5.09%
Hedge Fund
0.80%
Investment Advisor/Hedge Fund
0.64%
Other
46.83%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
38
4.28M
53.09%
-1.50K
2025Q1
39
4.88M
60.37%
-1.40K
2024Q4
36
4.88M
60.35%
-45.33K
2024Q3
31
4.73M
58.53%
-190.45K
2024Q2
32
4.72M
57.24%
-175.49K
2024Q1
34
4.70M
56.72%
-231.88K
2023Q4
36
4.69M
56.61%
-257.13K
2023Q3
34
4.69M
56.58%
-265.51K
2023Q2
34
4.80M
57.00%
-223.23K
2023Q1
36
5.70M
67.38%
-813.20K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Portnoy (David I)
1.57M
19.44%
--
--
Feb 28, 2025
Portnoy (Mark)
935.77K
11.58%
--
--
Feb 28, 2025
Fleishman (Adam)
509.00K
6.3%
--
--
Feb 28, 2025
Hamilton Lane Advisors, LLC
409.73K
5.07%
--
--
Jun 30, 2025
SFI Advisors LLC
165.30K
2.05%
--
--
Mar 31, 2025
The Vanguard Group, Inc.
118.23K
1.46%
+1.28K
+1.09%
Mar 31, 2025
The MassMutual Trust Company, FSB
111.03K
1.37%
--
--
Mar 31, 2025
Mikulinsky (Oleg)
104.35K
1.29%
--
--
Feb 28, 2025
Berger (Harold D)
50.40K
0.62%
--
--
Feb 28, 2025
Topline Capital Management, LLC
47.79K
0.59%
--
--
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
iShares Micro-Cap ETF
0.01%
iShares Micro-Cap ETF
Proporción0.01%
Dividendos
Un total de
9.69M
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Jan 29, 2025
CCEL.NB Interim Cash Dividend of gross USD 0.25 paid on Feb 28, 2025 going ex on Feb 14, 2025
Feb 14, 2025
Feb 28, 2025
Feb 14, 2025
Oct 31, 2024
CCEL.NB Interim Cash Dividend of gross USD 0.25 paid on Nov 29, 2024 going ex on Nov 15, 2024
Nov 15, 2024
Nov 29, 2024
Nov 15, 2024
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
